TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HAE

Haemonetics Corporation

Healthcare · Medical Devices

108.40$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,365 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HAE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,011 2,200 2,196 2,541 2,525 2,531 2,451 2,462 2,442 2,491 2,396 2,365
866 765 769 979 956 1,006 935 913 900 944 835 811
351 194 179 344 299 321 307 293 296 363 245 223
351 194 179 344 299 321 307 293 296 363 245 223
174 212 207 201 214 212 203 201 207 196 217 216
286 304 317 374 382 360 365 361 336 321 306 307
308 300 286 284 287 292 297
465 555 565 613 616 605 604 607 606 607 656 657
251 429 406 495 488 466 456 451 428 420 448 435
1,118 1,257 1,236 1,636 1,646 1,624 1,630 1,580 1,593 1,579 1,600 1,528
264 262 300 260 274 253 578 531 548 540 283 263
14 14 10 5.1 5.4 5.1 304 304 304 305 5.0 5.0
80 57 73 77 69 63 67 46 62 49 51 56
749 857 798 1,218 1,220 1,220 921 921 920 920 1,220 1,169
894 943 960 905 879 907 821 882 849 911 796 837
309 340 360 387 369 392 352 356 336 381 279 312
51 51 51 52 51 51 49 48 48 47 46 46

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?